Form EFFECT eFFECTOR Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 2, 2024 |
| Accession Number: | 0001193125-24-081971 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASMFC Advances Menhaden Addendum for Public Comment Despite No Clear Definition of the Problem It Seeks to Solve
- NANBPWC, Inc. Celebrates First Leadership Legacy Lab Cohort, Launches Fundraiser to Send Six Young Women to the United Nations for International Day of the Girl Child
- Mineros Delivers H1 Record Revenue of $559 Million and Record Adjusted EBITDA of $260 Million on Sales of 122,634 Gold Equivalent Ounces
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
